A panel of immunization experts that advises the U.S. Centers for Disease Control and Prevention will convene in April after ...
To join the GSK class action, go to https://rosenlegal.com/submit-form/?case_id=34609 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class ...
4h
Zacks Investment Research on MSNGILD Stock Down on Report of Cut in HIV Prevention SpendingShares of Gilead Sciences, Inc. GILD were down 2.47% after the Wall Street Journal reported that The Health and Human ...
British investment firm SV Health Investors has secured $250 million to go toward the development of first-in-class ...
PrimeC is NeuroSense's lead drug candidate for ALS, a novel extended-release oral formulation combining ciprofloxacin and celecoxib. The drug has demonstrated promising results in clinical trials, ...
We suggest that investors who own GSK's stock remain invested for now, considering its sales and profits are expected to continue improving in the coming years.
Pfizer PFE has sold off its remaining stake in consumer health company Haleon HLN to institutional investors and Haleon ...
A major employer in Dungarvan has seen Pfizer, its single largest shareholder, sell its entire stake in the company for ...
The pharmaceutical industry on Thursday blasted the UK government's levy that aims to curb the national health system's drugs ...
NEW YORK, NY / ACCESS Newswire / March 19, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results